Vaccine

Cognizant selected by CEPI to transform enterprise architecture and core ERP operations

OSLO, Norway, Nov. 20, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), a leading global professional services company, today announced that it has…

4 weeks ago

Safeguard Global Maps Hotspots to Find Pharma Talent in Inaugural Industry Intelligence Report

Industry Intelligence Report identifies hidden-gem markets to hire machine learning, QA, and bioprocess engineers and clinical leaders AUSTIN, Texas, Nov.…

1 month ago

TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the…

1 month ago

Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer

Strategic Hire Strengthens Late Phase and Commercial Readiness as Elicio Advances Lymph Node-Targeted Immunotherapy PipelineBOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE)…

1 month ago

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health®…

1 month ago

Moderna to Present at Upcoming Piper Sandler’s 37th Annual Healthcare Conference on December 2, 2025

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following…

1 month ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

Three BriaCell poster presentations include updated key biomarker data from BriaCell’s pivotal Phase 3 study and updated survival data from…

1 month ago

NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has…

1 month ago

Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin

SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health…

1 month ago

Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform

BOSTON, Nov. 14, 2025 /PRNewswire/ -- Volta Labs, a leader in automation for genomics, and New England Biolabs® (NEB®), a world-renowned…

1 month ago